Y Intercept Hong Kong Ltd reduced its position in Cognex Corporation (NASDAQ:CGNX – Free Report) by 87.8% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 18,640 shares of the scientific and technical instruments company’s stock after selling 134,266 shares during the quarter. Y Intercept Hong Kong Ltd’s holdings in Cognex were worth $913,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CGNX. Royal Bank of Canada raised its position in shares of Cognex by 13.2% in the first quarter. Royal Bank of Canada now owns 200,351 shares of the scientific and technical instruments company’s stock valued at $5,976,000 after buying an additional 23,326 shares during the last quarter. Empowered Funds LLC purchased a new position in shares of Cognex in the first quarter worth about $291,000. Intech Investment Management LLC boosted its position in Cognex by 24.1% during the first quarter. Intech Investment Management LLC now owns 47,444 shares of the scientific and technical instruments company’s stock worth $1,415,000 after acquiring an additional 9,223 shares during the last quarter. Geneos Wealth Management Inc. boosted its position in Cognex by 402.2% during the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock worth $27,000 after acquiring an additional 736 shares during the last quarter. Finally, Cetera Investment Advisers grew its stake in Cognex by 7.5% during the 2nd quarter. Cetera Investment Advisers now owns 13,208 shares of the scientific and technical instruments company’s stock valued at $419,000 after acquiring an additional 920 shares in the last quarter. Hedge funds and other institutional investors own 88.12% of the company’s stock.
Insider Activity
In related news, VP Darren Marc Long sold 20,252 shares of Cognex stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $66.34, for a total value of $1,343,517.68. Following the completion of the transaction, the vice president owned 3,990 shares in the company, valued at approximately $264,696.60. The trade was a 83.54% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Mark Fennell sold 64,873 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $67.05, for a total transaction of $4,349,734.65. Following the sale, the insider directly owned 11,263 shares in the company, valued at approximately $755,184.15. The trade was a 85.21% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 224,847 shares of company stock valued at $14,975,098. 1.70% of the stock is currently owned by company insiders.
Cognex Stock Performance
Cognex (NASDAQ:CGNX – Get Free Report) last announced its earnings results on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 EPS for the quarter, beating analysts’ consensus estimates of $0.25 by $0.09. The company had revenue of $268.44 million during the quarter, compared to analysts’ expectations of $245.98 million. Cognex had a return on equity of 10.89% and a net margin of 13.62%.Cognex’s revenue for the quarter was up 24.3% on a year-over-year basis. During the same period last year, the business posted $0.14 EPS. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. Research analysts predict that Cognex Corporation will post 1.48 EPS for the current fiscal year.
Cognex Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Thursday, June 4th. Stockholders of record on Thursday, May 21st were given a dividend of $0.085 per share. This represents a $0.34 annualized dividend and a dividend yield of 0.5%. The ex-dividend date of this dividend was Thursday, May 21st. Cognex’s dividend payout ratio is currently 40.48%.
Analysts Set New Price Targets
A number of research analysts have weighed in on CGNX shares. DA Davidson set a $62.00 target price on shares of Cognex and gave the stock a “neutral” rating in a research note on Thursday, May 14th. The Goldman Sachs Group restated a “buy” rating and issued a $80.00 price target (up from $70.00) on shares of Cognex in a research report on Monday, May 11th. Robert W. Baird set a $72.00 price target on Cognex in a report on Friday, May 8th. Truist Financial lifted their price objective on Cognex from $61.00 to $71.00 and gave the stock a “hold” rating in a research report on Thursday, July 2nd. Finally, Barclays reissued an “overweight” rating and set a $75.00 price objective (up from $64.00) on shares of Cognex in a research note on Monday, May 11th. Two investment analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $72.00.
View Our Latest Report on CGNX
Cognex Profile
Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.
The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.
Recommended Stories
- Five stocks we like better than Cognex
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
- Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Corporation (NASDAQ:CGNX – Free Report).
Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.
